Fig. 1: Relative change in sum of longest diameters of tumour lesions from baseline to post-baseline nadir for RECIST-evaluable patients (n = 25, Phase 1b study).
IHC immunohistochemistry.
Fig. 1: Relative change in sum of longest diameters of tumour lesions from baseline to post-baseline nadir for RECIST-evaluable patients (n = 25, Phase 1b study). | British Journal of Cancer
